ALLIANCEBERNSTEIN L.P. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$71,624,612
+2576.4%
2,716,140
+1645.7%
0.03%
+2900.0%
Q2 2023$2,676,165
+21.6%
155,591
+17.2%
0.00%0.0%
Q1 2023$2,201,128
+117.3%
132,758
-0.2%
0.00%
Q4 2022$1,013,140
-23.4%
132,9580.0%0.00%
-100.0%
Q3 2022$1,322,000
-54.2%
132,958
-58.2%
0.00%0.0%
Q2 2022$2,889,000
-20.2%
318,216
-10.8%
0.00%0.0%
Q1 2022$3,621,000
-47.9%
356,732
-14.4%
0.00%
-50.0%
Q4 2021$6,954,000
+7.7%
416,930
+202.8%
0.00%
-33.3%
Q3 2021$6,454,000
-22.1%
137,698
+1.3%
0.00%0.0%
Q2 2021$8,287,000
-2.8%
135,948
-1.7%
0.00%
-25.0%
Q1 2021$8,523,000
+15.3%
138,358
+33.1%
0.00%
+33.3%
Q4 2020$7,394,000
+89.5%
103,9840.0%0.00%
+50.0%
Q3 2020$3,901,000
+12.4%
103,984
-2.3%
0.00%0.0%
Q2 2020$3,470,000
+20.1%
106,417
+6.8%
0.00%0.0%
Q1 2020$2,889,000
+200.3%
99,617
+262.9%
0.00%
+100.0%
Q4 2019$962,00027,4530.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders